Status:

WITHDRAWN

Blood Cell Response to Exercise

Lead Sponsor:

USDA Grand Forks Human Nutrition Research Center

Conditions:

Metabolic Syndrome

Eligibility:

All Genders

30-60 years

Brief Summary

Moderate exercise is recommended to improve cardiovascular health in obese and overweight people particularly with metabolic syndrome (MetS) that have hypertension, elevated fasting blood sugar, and e...

Eligibility Criteria

Inclusion

  • 30-60 years old
  • BMI \>/=26 and \<40 kg/m2
  • not planning to or currently attempting to gain or lose weight
  • low reported omega-3 fatty acid intake per Omega-3 Checklist
  • Metabolic Syndrome as define 3/5 of the following:Waist circumference: men \> 102 cm women \> 88 cm, triglycerides \> 150 mg/dL, HDL cholesterol: men \< 40 mg/dL women \< 50 mg/dL,Blood pressure \>130/\>85 mmHg,Fasting glucose \> 100 mg/dL (Hypertensive subjects are eligible if taking thiazide diuretics NOT ACE inhibitors beta blockers)

Exclusion

  • smoke or use tobacco or nicotine in any form (including pills and patches)
  • take any medication that makes you unable to exercise
  • have established cardiovascular, pulmonary, and/or metabolic disease such as diabetes
  • have uncontrolled hypertension
  • have alcohol, anabolic steroid, or other substance abuse issues
  • consume more than 3 alcoholic drinks/week
  • have joint or muscle injuries that affects your ability to exercise
  • have cancer (other than skin cancer or carcinoma in situ of the cervix
  • pregnant or lactating
  • currently exercise regularly
  • taking non-steroidal anti-inflammatory medications (aspirin, Aleve, Advil, ibuprofen, naproxen
  • take lipid modifying medications such as statins (Lipitor, Zocor)
  • take medications for blood glucose such as insulin or metformin
  • take medications that affect platelet functions (Plavix)
  • taking omega-3 supplements (fish or flax oil)

Key Trial Info

Start Date :

February 1 2013

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

June 1 2016

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT01872273

Start Date

February 1 2013

End Date

June 1 2016

Last Update

February 2 2022

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Blood Cell Response to Exercise | DecenTrialz